Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Tompkins
    4. ›
  4. 11228
    5. ›
  5. JAN BIOTECH, INC.

JAN BIOTECH, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: JAN BIOTECH, INC.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 19 Nov 2013 (12 years ago)
Entity Number: 4489702
ZIP code: 11228
County: Tompkins
Place of Formation: New York
Address: 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, United States, 11228
Principal Address: 1201 GREENFIELD LN, Skaneateles, NY, United States, 13152

Shares Details

Shares issued 12000000

Share Par Value 0.001

Type PAR VALUE

DOS Process Agent

Name Role Address
C/O UNITED STATES CORPORATION AGENTS, INC. DOS Process Agent 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, United States, 11228

Agent

Name Role Address
UNITED STATES CORPORATION AGENTS, INC. Agent 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, 11228

Chief Executive Officer

Name Role Address
JENNIFER A. NICHOLS Chief Executive Officer 1201 GREENFIELD LN, SKANEATELES, NY, United States, 13152

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Website:
http://www.janbiotech.com
Phone Number:
607-379-1972
E-mail Address:
janhuie@janbiotech.com
Contact Person:
JANET HUIE
Ownership and Self-Certifications:
Women-Owned Small Business, Woman Owned
User ID:
P1811508
Trade Name:
JBI

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
DKDUTDKCJQE6
CAGE Code:
71ZJ8
UEI Expiration Date:
2025-09-23

Business Information

Doing Business As:
JBI
URL:
http://www.janbiotech.com
Activation Date:
2024-09-25
Initial Registration Date:
2014-01-30

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
71ZJ8
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-09-25
CAGE Expiration:
2029-09-25
SAM Expiration:
2025-09-23

Contact Information

POC:
JANET L. HUIE
Corporate URL:
http://www.janbiotech.com

History

Start date End date Type Value
2023-11-16 2023-11-16 Address 1201 GREENFIELD LN, SKANEATELES, NY, 13152, USA (Type of address: Chief Executive Officer)
2023-10-24 2023-11-16 Shares Share type: PAR VALUE, Number of shares: 12000000, Par value: 0.001
2013-11-19 2023-10-24 Shares Share type: PAR VALUE, Number of shares: 12000000, Par value: 0.001
2013-11-19 2023-11-16 Address 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, 11228, USA (Type of address: Registered Agent)
2013-11-19 2023-11-16 Address 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, 11228, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
231116001227 2023-11-16 BIENNIAL STATEMENT 2023-11-01
210715001929 2021-07-15 BIENNIAL STATEMENT 2021-07-15
131119000962 2013-11-19 CERTIFICATE OF INCORPORATION 2013-11-19

USAspending Awards / Contracts

Procurement Instrument Identifier:
HT942524C0079
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
0.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2024-09-20
Description:
DHA SBIR DIRECT PHASE II H2D-0219 SAMPLE COLLECTION AND PROCESSING METHODS TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AN12: HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Procurement Instrument Identifier:
W911NF20C0014
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DEFINITIVE CONTRACT
Action Obligation:
0.00
Base And Exercised Options Value:
0.00
Base And All Options Value:
0.00
Awarding Agency Name:
Department of Defense
Performance Start Date:
2019-11-21
Description:
STTR PHASE II- HYBRID NANO-BIO-ELECTRONIC ODOR DETECTOR
Naics Code:
541714: RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
Product Or Service Code:
AZ11: R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH)
Procurement Instrument Identifier:
W911NF19P0014
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
PURCHASE ORDER
Action Obligation:
149999.53
Base And Exercised Options Value:
149999.53
Base And All Options Value:
149999.53
Awarding Agency Name:
Department of Defense
Performance Start Date:
2018-12-18
Description:
HYBRID NANO-BIO-ELECTRONIC ODOR DETECTOR
Naics Code:
541715: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product Or Service Code:
AZ11: R&D- OTHER RESEARCH AND DEVELOPMENT (BASIC RESEARCH)

USAspending Awards / Financial Assistance

Date:
2023-08-18
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
PEDIATRIC LATENT HIV RESERVOIR CHARACTERIZATION AND QUANTIFICATION ASSAY - PROJECT SUMMARY ABSTRACT PUBLIC HEALTH PROBLEM MODERN ANTIRETROVIRAL THERAPY (ART) COMBINATIONS GREATLY IMPROVE SURVIVAL OF HIV INFECTED INDIVIDUALS AND REDUCE HIV TRANSMISSION. HOWEVER, THERE ARE STILL 38 MILLION PEOPLE LIVING WITH HIV (PWH) WORLDWIDE AND OF THOSE 1.8 MILLION ARE CHILDREN UNDER THE AGE OF 15, HIGHLIGHTING THE IMPERATIVE NEED FOR CURATIVE THERAPIES. IN LIMITED RESOURCE AREAS, WHERE PEDIATRIC HIV IS MOST COMMON, THE USE OF NEW ASSAYS THAT REQUIRE LESS BLOOD VOLUMES, LOWER COST AND LESS LABOR-INTENSIVE METHODS ARE NECESSARY TO FACILITATE CLINICAL TRIALS AIMED AT REDUCING THE SIZE OF THE LATENT RESERVOIR AND/OR TO ACHIEVE A CURE OR ART-FREE REMISSION. THE ULTIMATE VALUE OF THE SBIR PHASE I PROJECT WILL DEMONSTRATE THE ABILITY OF OUR TECHNOLOGY TO CHARACTERIZE AND QUANTIFY THE PEDIATRIC HIV-1 RESERVOIR, WHICH REMAINS A CRITICAL UNMET NEED IN THE HIV CURE FIELD. ISSUES WITH CURRENT SOLUTIONS & HOW PRODUCT MEETS UNMET NEEDS RNAAMP ALLOWS DIRECT DETECTION OF RNA, WHICH PROVIDES THE MOST ACCURATE MEASURE OF THE HIV REPLICATION COMPETENT RESERVOIR. THE ASSAY IS PROVEN TO BE FASTER AND HAVE BETTER RELIABILITY AND QUANTIFICATION THAN HIV RESERVOIR ASSAYS BASED ON QVOA, RT-QPCR, RT-DDPCR, ISCA AND IPDA. RNA TARGET AMPLIFICATION AND DETECTION IS ACCOMPLISHED BY OLIGONUCLEOTIDE-TEMPLATED PHOTOREDUCTION USING SHORT, SEQUENCE-SPECIFIC PROFLUOROPHORE AND CATALYTIC PROBES. REPRODUCIBILITY IS OUTSTANDING (4% VARIANCE BETWEEN REPLICATES) AND LIMIT OF DETECTION (LOD) IS 1 HIV-INFECTED CELLS/1 X 106 PBMCS OR 1-10 RNA COPIES/ML, USING A STANDARD BLOOD DRAW (10-30 ML). JAN BIOTECH’S RNAAMP QUICK, DIRECT RNA TEST, WITH ITS USE OF SMALL BLOOD SAMPLES, EASE OF SAMPLE PREPARATION, RELIABILITY AND SENSITIVITY, QUANTITATIVE ABILITY AND SHORT TIME TO RESULT, IS IDEALLY SUITED FOR CHARACTERIZATION AND QUANTIFICATION OF THE REBOUND-COMPETENT PEDIATRIC HIV RESERVOIR. SUMMARY OF APPROACH JAN BIOTECH HAS DEVELOPED AN ASSAY WITH A PREDICTION ACCURACY OF 0.92 FOR TIME TO REBOUND AFTER TREATMENT INTERRUPTION FOR EARLY/ACUTE-TREATED ADULT PARTICIPANTS. THE ASSAY, RNAAMP, UTILIZES NONEZYMATIC, CHEMICAL AMPLIFICATION OF CELL-ASSOCIATED HIV RNA TARGETS TO PROVIDE QUICK, SENSITIVE, AND QUANTITATIVE MEASUREMENT OF THE HIV RESERVOIR. NO OTHER ASSAY, INCLUDING QVOA, IPDA, ISCA, RT-QPCR, OR RT-DDPCR, PROVIDED A PREDICTION ACCURACY OF GREATER THAN 0.2 FOR THE SAME ADULT PARTICIPANTS. THIS PROPOSAL IS TO DEVELOP RNAAMP FOR CROSS- SUBTYPE (I.E., NON-B SUBTYPE) HIV RESERVOIR DETECTION, SPECIFICALLY FOR PEDIATRIC TESTING, FOR WHICH THE USE OF SMALL SAMPLES EASILY TESTED BY RNAAMP IS CRUCIAL. PEDIATRIC HIV-INFECTED INDIVIDUALS ARE TYPICALLY TREATED DURING EARLY HIV INFECTION, OFTEN TREATED AT BIRTH, AND PHYSICIAN-MONITORED OR SPONTANEOUS TREATMENT INTERRUPTION IS MORE FREQUENT IN THIS POPULATION. PEDIATRIC TREATMENT EFFICACY AND TREATMENT INTERRUPTION CLINICAL TRIALS TYPICALLY INCLUDE NON-B SUBTYPE HIV-INFECTED PARTICIPANTS. COLLABORATORS AND UNIQUE RESOURCES JAN BIOTECH, INC., WITH EXPERTISE IN MOLECULAR DIAGNOSTIC DEVELOPMENT, WILL CONSULT WITH JONATHAN LI, MD, MMSC ASSISTANT PROFESSOR OF MEDICINE, HARVARD MEDICAL SCHOOL, IN A AIDS CLINICAL TRIALS GROUP (ACTG) STUDY AND HARRIS GELBARD, MD, PHD, UNIVERSITY OF ROCHESTER MEDICAL SCHOOL. PHASE I SPECIFIC AIMS SPECIFIC AIM 1: DEVELOP HIV-1 CROSS-SUBTYPE (CS) RNAAMP MULTIPLEXED ASSAY SPECIFIC AIM 2: CORRELATE CS-RNAAMP TO POL RT-QPCR USING NON-B SUBTYPE HIV-INFECTED CELLS SPECIFIC AIM 3: PEDIATRIC HUMAN SAMPLE TESTING USING CS-RNAAMP HIV RESERVOIR CHARACTERIZATION MARKET AFTER PHASE II COMPLETION BOTH GILEAD AND MERCK ARE COMMERCIALLY INTERESTED IN THE TECHNOLOGY. REGULATORY APPROVAL WILL BE SOUGHT FOR COMMERCIALIZATION.
Obligated Amount:
300000.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2022-08-09
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
RAPID COVID-19 MUTATION DISCRIMINATION TEST FOR GLOBAL SARS-COV-2 VARIANT SURVEILLANCE
Obligated Amount:
275766.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-08-07
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
SEQUENCE-BASED RNA FLUORESCENCE ASSAY TO MEASURE LATENT HIV RESERVOIRS
Obligated Amount:
2291256.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2016-06-13
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
DEVELOPMENT OF A CONTROL KIT FOR LATENT HIV DIAGNOSTICS
Obligated Amount:
288893.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2015-08-17
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
REAL-TIME SPLICED-RNA DETECTION TO QUANTIFY LATENT HIV-INFECTED CELLS IN HAART PATIENTS
Obligated Amount:
356556.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

Trademarks Section

Serial Number:
86573344
Mark:
SUPPORTING THE CURE
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2015-03-23
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
SUPPORTING THE CURE
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Diagnostic agents, preparations and substances for medical purposes
International Classes:
005 - Primary Class
Class Status:
Active
For:
Diagnostic preparations for clinical or medical laboratory use
International Classes:
001 - Primary Class
Class Status:
Active

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

C/O UNITED STATES CORPORATION AGENTS, INC.

"DO ME A FAVOR" PARTY FAVORS & NOVELITIES LLC #1 TAXI SERVICE, LLC #HEALTHY IS IN, LLC #IKEBOY MUSIC GROUP LLC & TER MEER, LLC '90 TILL, LLC 0311 INVESTIGATIONS & SECURITY, LLC 07760 LLC 0X70, LLC 1 STOP SOURCE SUPPLIES, INC.

UNITED STATES CORPORATION AGENTS, INC.

"KING OF THE "WORLD" SIR BARRY K BALDWIN JR LLC "THIS IS THE WAY WALK IN IT" ISAIAH 30:21 INC. "WHAT'S UP SKYLIGHTS LLC #1 FOOD SPOT LLC #1 PREVALENT BRAND INC. #1 TAXI SERVICE, LLC #BAGTALKENT, LLC #BELLASTRONG INC. #REALNESS BY ALYMARIE, LLC #YKTV LLC

Related by address

7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, United States, 11228

"WJ" MAC INCORPORATED #2THECOURTS, INC. #FILMS, LLC #HEALTHY IS IN, LLC #HELPTHEHUNGRY CORPORATION #IKEBOY MUSIC GROUP LLC #JUSTKEEPRUNNING, LLC #LOVE IT? GET IT!, LLC #REALNESS BY ALYMARIE, LLC #THECLASSICPLAYLISTFAM LLC

Date of last update: 26 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated